Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Priority to CU20080249ApriorityCriticalpatent/CU20080249A7/en
Publication of CU20080249A7publicationCriticalpatent/CU20080249A7/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a una formulación farmacológica acuosa que contiene ácido 4-[((4-carboxibutil)-{2-[(4-fenetilbencil)oxi]fenetil}-amino)metil]benezoico ouna de sus sales. En especial, rboxibutil)-{2-[(4fenetilbencil)oxi]fenetil}amino)metil]benzoico o una de sus sales y amino-2-(hidroximetil)-2-propanodiol-1,3 (trometamol).The present invention relates to an aqueous pharmacological formulation containing 4 - [((4-carboxybutyl) - {2 - [(4-phenethylbenzyl) oxy] phenethyl} -amino) methyl] benezoic acid or a salt thereof. In particular, rboxibutyl) - {2 - [(4-phenethylbenzyl) oxy] phenethyl} amino) methyl] benzoic or one of its salts and amino-2- (hydroxymethyl) -2-propanediol-1,3 (tromethamine).
CRYSTAL POLYMAL SALES AND FORMS OF [4- (6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-IL) -PENYL] -5-CHLORINE-THIOPHEN-2- IL-SULFONIL UREA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD TO PREPARE THEM AND USE OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATE